Lack of specific (3H) prazosin binding sites in dog and rabbit cerebral arteries.
In order to explore the characteristics of alpha adrenergic receptors on cerebrovascular smooth muscle, specific binding sites for the alpha 1 adrenergic ligand, (3H) prazosin, were studied in blood vessel homogenates. No specific (3H) prazosin binding was found in either rabbit or dog cerebral arteries, but specific binding was demonstrated in the rabbit saphenous and ear arteries. In the ear artery 3H-prazosin binding was saturable with a Kd of 0.51 +/- 0.20 nM and a Bmax of 89 +/- 29 fmoles/mg protein. To confirm the adequacy of our membrane preparation, homogenates of both dog and rabbit cerebral arteries showed saturable specific binding with two different ligands: one for muscarinic receptors, [3H](-) quinuclidinyl benzilate (QNB) and one for alpha 2 adrenergic receptors, (3H) yohimbine. The results of these studies demonstrate a lack of alpha 1 adrenergic receptors on cerebral blood vessels, confirming functional studies showing only a weak contractile response to norepinephrine.
D000818:Animals; D001158:Arteries / Q000378:metabolism; D002536:Cerebral Arteries / Q000378:metabolism*; D004285:Dogs; D004423:Ear / Q000098:blood supply; D005260:Female; D008297:Male; D011224:Prazosin / Q000378:metabolism*; D011799:Quinazolines / Q000378:metabolism*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000378:metabolism; D015016:Yohimbine / Q000378:metabolism
D011799:Quinazolines; D011942:Receptors, Adrenergic, alpha; D011976:Receptors, Muscarinic; D015016:Yohimbine; D011813:Quinuclidinyl Benzilate; D011224:Prazosin